- Research works
- 54 ▲ 72% vs 2013–17
- Citations
- 2.7k 50.7 per fractional work
- Top-10% rate
- 14.0% record average 16.5%
- Open access
- 41% world 28%
Not ranked overall: Nordic Lymphoma Group is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at Nordic Lymphoma Group?
By fractional works in all years, weighted toward what it does more of than the world: Clinical Practice Guidelines, Lymphoma, Rituximab, Chemotherapy, Clinical Trials, Prognostic Factors, Neoadjuvant Therapy and PET Imaging.
- Screening
- Colonoscopy
- Soft Tissue Sarcoma
- Immunosuppression
- Tumor Microenvironment
- Cancer Incidence
- Colorectal Cancer
- Leukemia
- Natural Killer Cells
- Mortality
- Guidelines
- Rectal Cancer
- EGFR Mutations
- Treatment Guidelines
- Laparoscopic Surgery
- Classification
- PET Imaging
- Neoadjuvant Therapy
- Chemotherapy
- Lymphoma
- Clinical Practice Guidelines
- Rituximab
- Clinical Trials
- Prognostic Factors
- Adjuvant Chemotherapy
- Molecular Profiling
- Targeted Therapy
- ALK Inhibitors
- Preoperative Chemoradiotherapy
- Tumor Markers
- Immunotherapy
- NK Cell Recognition
- Survival Analysis
- Radiotherapy
- Cancer Immunotherapy
- Robotic Surgery
- Chemoradiotherapy
- Osteosarcoma
- Chronic Lymphocytic Leukemia
- Genomic Aberrations
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Clinical Practice Guidelines6▲ 20×6 topics
- Lymphoma5▲ 64×3 topics
- Rituximab5▲ 56×3 topics
- Chemotherapy5▲ 12×13 topics
- Clinical Trials4▲ 11×4 topics
- Neoadjuvant Therapy4▲ 30×5 topics
- Prognostic Factors4▲ 15×5 topics
- PET Imaging4▲ 30×2 topics
- Adjuvant Chemotherapy3▲ 87×2 topics
- Classification3▲ 17×1 topic
- Molecular Profiling3▲ 52×1 topic
- Laparoscopic Surgery3▲ 52×3 topics
- Targeted Therapy3▲ 27×2 topics
- Treatment Guidelines3▲ 28×3 topics
- ALK Inhibitors3▲ 94×1 topic
- EGFR Mutations3▲ 94×1 topic
- Preoperative Chemoradiotherapy3▲ 73×2 topics
- Rectal Cancer3▲ 143×1 topic
- Tumor Markers3▲ 73×1 topic
- Guidelines2▲ 9.1×6 topics
- Immunotherapy2▲ 6.7×6 topics
- Mortality2▲ 7.8×3 topics
- NK Cell Recognition2▲ 34×1 topic
- Natural Killer Cells2▲ 34×1 topic
- Survival Analysis2▲ 13×4 topics
- Leukemia2▲ 52×2 topics
- Radiotherapy2▲ 9.0×6 topics
- Colorectal Cancer2▲ 33×3 topics
- Cancer Immunotherapy2▲ 21×2 topics
- Cancer Incidence2▲ 22×4 topics
- Robotic Surgery2▲ 20×3 topics
- Tumor Microenvironment2▲ 8.0×6 topics
- Chemoradiotherapy1▲ 48×2 topics
- Immunosuppression1▲ 22×2 topics
- Osteosarcoma1▲ 47×1 topic
- Soft Tissue Sarcoma1▲ 40×1 topic
- Chronic Lymphocytic Leukemia1▲ 51×1 topic
- Colonoscopy1▲ 63×1 topic
- Genomic Aberrations1▲ 51×1 topic
- Screening1▲ 26×1 topic
Which research topics does Nordic Lymphoma Group publish most on?
By volume in 2022–2025: Colorectal Cancer Surgical Treatments, Immune Cell Function and Interaction, Lymphoma Diagnosis and Treatment and CAR-T cell therapy research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Colorectal Cancer Surgical Treatments Oncology 1 works
- 2 Immune Cell Function and Interaction Immunology 0 works
- 3 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
- 4 CAR-T cell therapy research Oncology 0 works
- 5 Cultural Industries and Urban Development Urban Studies 0 works
- 6 Colorectal Cancer Screening and Detection Oncology 0 works
- 7 Stoma care and complications Surgery 0 works
- 8 Anorectal Disease Treatments and Outcomes Surgery 0 works
- 9 Genetic factors in colorectal cancer Pathology and Forensic Medicine 0 works
- 10 Cancer, Lipids, and Metabolism Cancer Research 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Nordic Lymphoma Group's research output changed?
Output in 2018–2022 was 72% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Copenhagen
- University of Copenhagen
- Rigshospitalet
- Copenhagen Business School
- Copenhagen University Hospital
- Gentofte Hospital
- Bispebjerg Hospital
- Statens Serum Institut
- Novo Nordisk (Denmark)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.